JP2009034115A5 - - Google Patents

Download PDF

Info

Publication number
JP2009034115A5
JP2009034115A5 JP2008287206A JP2008287206A JP2009034115A5 JP 2009034115 A5 JP2009034115 A5 JP 2009034115A5 JP 2008287206 A JP2008287206 A JP 2008287206A JP 2008287206 A JP2008287206 A JP 2008287206A JP 2009034115 A5 JP2009034115 A5 JP 2009034115A5
Authority
JP
Japan
Prior art keywords
cells
process according
influenza virus
culture medium
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008287206A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009034115A (ja
Filing date
Publication date
Priority claimed from DE19612966A external-priority patent/DE19612966B4/de
Application filed filed Critical
Publication of JP2009034115A publication Critical patent/JP2009034115A/ja
Publication of JP2009034115A5 publication Critical patent/JP2009034115A5/ja
Withdrawn legal-status Critical Current

Links

JP2008287206A 1996-04-01 2008-11-07 インフルエンザウイルスの複製のための動物細胞および方法 Withdrawn JP2009034115A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19612966A DE19612966B4 (de) 1996-04-01 1996-04-01 MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006147486A Division JP2006230415A (ja) 1996-04-01 2006-05-26 インフルエンザウイルスの複製のための動物細胞および方法

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011192118A Division JP2012005502A (ja) 1996-04-01 2011-09-02 インフルエンザウイルスの複製のための動物細胞および方法
JP2011224914A Division JP2012016358A (ja) 1996-04-01 2011-10-12 インフルエンザウイルスの複製のための動物細胞および方法

Publications (2)

Publication Number Publication Date
JP2009034115A JP2009034115A (ja) 2009-02-19
JP2009034115A5 true JP2009034115A5 (enExample) 2009-12-24

Family

ID=7790126

Family Applications (7)

Application Number Title Priority Date Filing Date
JP53508997A Expired - Fee Related JP4243349B2 (ja) 1996-04-01 1997-04-01 インフルエンザウイルスの複製のための動物細胞および方法
JP2004233905A Withdrawn JP2004331673A (ja) 1996-04-01 2004-08-10 インフルエンザウイルスの複製のための動物細胞および方法
JP2005108075A Withdrawn JP2005211080A (ja) 1996-04-01 2005-04-04 インフルエンザウイルスの複製のための動物細胞および方法
JP2006147486A Withdrawn JP2006230415A (ja) 1996-04-01 2006-05-26 インフルエンザウイルスの複製のための動物細胞および方法
JP2008287206A Withdrawn JP2009034115A (ja) 1996-04-01 2008-11-07 インフルエンザウイルスの複製のための動物細胞および方法
JP2011192118A Withdrawn JP2012005502A (ja) 1996-04-01 2011-09-02 インフルエンザウイルスの複製のための動物細胞および方法
JP2011224914A Withdrawn JP2012016358A (ja) 1996-04-01 2011-10-12 インフルエンザウイルスの複製のための動物細胞および方法

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP53508997A Expired - Fee Related JP4243349B2 (ja) 1996-04-01 1997-04-01 インフルエンザウイルスの複製のための動物細胞および方法
JP2004233905A Withdrawn JP2004331673A (ja) 1996-04-01 2004-08-10 インフルエンザウイルスの複製のための動物細胞および方法
JP2005108075A Withdrawn JP2005211080A (ja) 1996-04-01 2005-04-04 インフルエンザウイルスの複製のための動物細胞および方法
JP2006147486A Withdrawn JP2006230415A (ja) 1996-04-01 2006-05-26 インフルエンザウイルスの複製のための動物細胞および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011192118A Withdrawn JP2012005502A (ja) 1996-04-01 2011-09-02 インフルエンザウイルスの複製のための動物細胞および方法
JP2011224914A Withdrawn JP2012016358A (ja) 1996-04-01 2011-10-12 インフルエンザウイルスの複製のための動物細胞および方法

Country Status (9)

Country Link
US (4) US6455298B1 (enExample)
EP (2) EP0904351B1 (enExample)
JP (7) JP4243349B2 (enExample)
AT (1) ATE482267T1 (enExample)
DE (2) DE19612966B4 (enExample)
DK (1) DK0904351T3 (enExample)
ES (1) ES2352638T3 (enExample)
PT (1) PT904351E (enExample)
WO (1) WO1997037000A1 (enExample)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
CA2306634C (en) * 1997-10-25 2005-04-12 Roche Diagnostics Gmbh Suspension packing cell lines for retrovirus vectors
DK1060241T4 (da) 1997-12-24 2011-01-24 Solvay Biologicals Bv Frembringelse af celler til fremstilling af biologiske materialer
WO2001064846A1 (fr) * 2000-03-03 2001-09-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cellule utilisable pour culture sans serum et culture en suspension, et procede de production de virus pour vaccin utilisant cette cellule
JP3547715B2 (ja) * 2001-03-06 2004-07-28 榮 新垣 ベクター精製用装置及び方法
DE10144903A1 (de) * 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
DE10144906B4 (de) * 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US20030078471A1 (en) * 2001-10-18 2003-04-24 Foley Frederick J. Manipulation of an organ
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
CN1678345A (zh) 2002-04-26 2005-10-05 米迪缪尼疫苗股份有限公司 制备流感病毒的多质粒系统
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
CA2807534A1 (en) 2003-02-25 2005-02-17 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
CA2503774C (en) * 2003-06-20 2007-09-25 Microbix Biosystems Inc. Improvements in virus production
JPWO2005026333A1 (ja) * 2003-09-09 2006-11-16 独立行政法人科学技術振興機構 プロテアーゼを用いた接着性細胞の浮遊培養技術、及び該細胞を宿主として用いてウイルスを生産する方法
ATE469972T1 (de) * 2003-12-23 2010-06-15 Medimmune Llc Multiplasmid-system zur erzeugung des grippevirus
DE202005022108U1 (de) 2004-03-09 2013-11-12 Novartis Vaccines And Diagnostics, Inc. Influenza-Virus-Impfstoffe
CA2562932A1 (en) * 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine
US20080254067A1 (en) * 2004-05-20 2008-10-16 Id Biomedical Corporation Process for the Production of an Influenza Vaccine
PL2236155T3 (pl) 2004-09-09 2012-10-31 Novartis Ag Zmniejszenie potencjalnego zagrożenia jatrogennego związanego ze szczepionkami przeciwko grypie
KR101376889B1 (ko) 2004-10-06 2014-03-25 메디뮨 엘엘씨 냉장 온도 안정성 인플루엔자 백신 조성물
DE102004049290A1 (de) * 2004-10-09 2006-04-20 Bayer Healthcare Ag Verfahren zur Herstellung von Virusmaterial
EP2923711A1 (en) 2004-11-03 2015-09-30 Novartis Vaccines and Diagnostics, Inc. Influenza vaccination
CA2593036A1 (en) 2004-12-08 2006-06-15 Medimmune Vaccines, Inc. Methods of producing influenza vaccine compositions
CN103555670B (zh) * 2004-12-23 2015-08-12 米迪缪尼有限公司 用于病毒增殖的非致瘤性mdck细胞系
US7572620B2 (en) 2005-01-11 2009-08-11 Wisconsin Alumni Research Foundation H3 equine influenza A virus
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
US20070111309A1 (en) * 2005-10-04 2007-05-17 Daelli Marcelo G Vero cell line adapted to grow in suspension
ES2359214T5 (es) 2005-11-01 2014-10-08 Novartis Vaccines And Diagnostics Gmbh Vacunas virales derivadas de células con niveles reducidos de ADN celular residual por tratamiento con beta-propiolactona
PL1945252T3 (pl) 2005-11-04 2013-11-29 Seqirus Uk Ltd Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant
PL1951299T3 (pl) 2005-11-04 2012-07-31 Novartis Ag Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
US20090304742A1 (en) 2005-11-04 2009-12-10 Novartis Vaccines And Diagnostics Srl Influenza vaccines with reduced amount of emulsion adjuvant
BRPI0618254A2 (pt) 2005-11-04 2011-08-23 Novartis Vaccines & Diagnostic emulsões com agente tensoativo de fase aquosa livre para fornecer adjuvante às vacinas contra influenza dividido
CN102755645A (zh) 2005-11-04 2012-10-31 诺华疫苗和诊断有限公司 佐剂配制的包含细胞因子诱导剂的流感疫苗
KR20080089663A (ko) 2006-01-27 2008-10-07 노바티스 백신즈 앤드 다이아그노스틱스 게엠베하 운트 콤파니 카게 적혈구응집소 및 기질 단백질을 함유한 인플루엔자 백신
JP2009534303A (ja) * 2006-03-24 2009-09-24 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー 冷蔵しないインフルエンザワクチンの保存
JP2009532352A (ja) 2006-03-31 2009-09-10 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション ワクチンのための高力価組み換えインフルエンザ・ウィルス
US7883844B2 (en) 2006-05-11 2011-02-08 Juridical Foundation The Chemosero-Therapeutic Research Institute Method for propagating influenza virus
GB0614460D0 (en) 2006-07-20 2006-08-30 Novartis Ag Vaccines
WO2008032219A2 (en) * 2006-09-11 2008-03-20 Novartis Ag Making influenza virus vaccines without using eggs
EP2069480B1 (en) * 2006-09-15 2014-03-19 MedImmune, LLC Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
CN101553252A (zh) 2006-12-06 2009-10-07 诺华有限公司 包含来自于四株流感病毒的抗原的疫苗
EP2069484B1 (en) 2007-06-18 2014-08-13 MedImmune, LLC Influenza B viruses having alterations in the hemaglutinin polypeptide
US9474798B2 (en) 2007-06-18 2016-10-25 Wisconsin Alumni Research Foundation Influenza M2 protein mutant viruses as live influenza attenuated vaccines
HRP20120790T1 (hr) * 2007-06-27 2013-01-31 Novartis Ag Cjepiva protiv influence sa niskom koliäśinom aditiva
ES2657055T3 (es) * 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
GB0810305D0 (en) 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
WO2009081172A1 (en) 2007-12-24 2009-07-02 Novartis Ag Assays for adsorbed influenza vaccines
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
ES2535101T3 (es) 2008-03-18 2015-05-05 Novartis Ag Mejoras en la preparación de antígenos en vacuna de virus de la gripe
TW201012930A (en) 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
RU2011107757A (ru) 2008-08-01 2012-09-10 Гамма Ваксинс Пти Лимитед (Au) Вакцины против гриппа
BRPI0919252A2 (pt) * 2008-09-24 2015-08-11 Medimmune Llc Métodos para cultivar células, propagação e purificação de vírus
CA2738024A1 (en) 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
WO2010079081A1 (en) 2009-01-07 2010-07-15 Glaxosmithkline Biologicals S.A. Methods for recovering a virus or a viral antigen produced by cell culture
EP2393922A1 (en) 2009-02-06 2011-12-14 GlaxoSmithKline Biologicals S.A. Purification of virus or viral antigens by density gradient ultracentrifugation
EP2396032B1 (en) 2009-02-10 2016-09-28 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene
WO2010092477A1 (en) 2009-02-10 2010-08-19 Novartis Ag Influenza vaccines with increased amounts of h3 antigen
WO2010092476A1 (en) 2009-02-10 2010-08-19 Novartis Ag Influenza vaccine regimens for pandemic-associated strains
CA2763816A1 (en) 2009-04-27 2010-11-04 Novartis Ag Adjuvanted vaccines for protecting against influenza
NZ596296A (en) 2009-05-08 2013-08-30 Novartis Ag Generic assays for detection of influenza viruses
EP2401384B1 (en) 2009-05-21 2012-10-03 Novartis AG Reverse genetics using non-endogenous pol i promoters
JP5823379B2 (ja) 2009-05-29 2015-11-25 ノバルティス アーゲー インフルエンザウイルスヘマグルチニンについてのアッセイ
CN102666860B (zh) 2009-07-31 2015-06-17 诺华股份有限公司 反向遗传系统
CA2773637A1 (en) 2009-09-10 2011-03-17 Novartis Ag Combination vaccines against respiratory tract diseases
SI2491117T1 (sl) 2009-10-20 2014-03-31 Novartis Ag Izboljšani postopki reverzne genetike za pridobivanje virusov
ES2813347T3 (es) 2009-10-26 2021-03-23 Wisconsin Alumni Res Found Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (en) 2009-12-03 2016-03-02 Novartis AG Circulation of components during homogenization and microfluidization of emulsions
NZ600254A (en) 2009-12-03 2013-10-25 Novartis Ag Arranging interaction and back pressure chambers for microfluidization
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506832B1 (en) 2009-12-03 2014-02-26 Novartis AG Hydrophilic filtration during manufacture of vaccine adjuvants
US20120309056A1 (en) 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
JP2013521771A (ja) 2010-03-08 2013-06-13 ノバルティス アーゲー 細胞内病原体について試験する方法
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
CA2797059A1 (en) 2010-05-03 2011-11-10 Glaxosmithkline Biologicals S.A. Novel method
BR112012028146A2 (pt) 2010-05-06 2015-09-15 Novartis Ag compostos de peróxido orgânico para inativação de microorganismos
CN105125488A (zh) 2010-05-12 2015-12-09 诺华股份有限公司 制备鲨烯的改良方法
JP5876036B2 (ja) 2010-05-21 2016-03-02 ノバルティス アーゲー インフルエンザウイルス再集合方法
US20130243841A1 (en) 2010-06-01 2013-09-19 Novartis Ag Concentration of vaccine antigens with lyophilization
DK2575872T3 (da) 2010-06-01 2020-10-19 Seqirus Uk Ltd Koncentrering af influenzavaccineantigener uden frysetørring
MX337687B (es) * 2010-08-16 2016-03-15 Cevec Pharmaceuticals Gmbh Linea celular de amniocitos humanos permanente para la produccion de virus de influenza.
US9051361B2 (en) 2010-08-17 2015-06-09 National Health Research Institutes Immunogenic compositions and uses thereof
US9517205B2 (en) 2010-08-20 2016-12-13 Seqirus UK Limited Soluble needle arrays for delivery of influenza vaccines
EP3012330A1 (en) 2010-09-07 2016-04-27 Novartis AG Generic assays for detection of mammalian reovirus
US20140079732A1 (en) 2011-01-27 2014-03-20 Gamma Vaccines Pty Limited Combination vaccines
JP5999817B2 (ja) 2011-02-25 2016-10-05 ノバルティス アーゲー 外因性の内部陽性対照
ES2655051T3 (es) 2011-08-26 2018-02-16 Wisconsin Alumni Research Foundation Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas
GB201216121D0 (en) 2012-09-10 2012-10-24 Novartis Ag Sample quantification by disc centrifugation
EP2768528A1 (en) 2011-10-20 2014-08-27 Novartis AG Adjuvanted influenza b virus vaccines for pediatric priming
JP2016539314A (ja) 2011-12-12 2016-12-15 ノバルティス アーゲー インフルエンザウイルス血球凝集素のためのアッセイ法
AU2014203051C1 (en) * 2012-03-02 2016-09-01 Seqirus UK Limited Influenza Virus Reassortment
ES2628301T3 (es) * 2012-03-02 2017-08-02 Seqirus UK Limited Recombinación de virus de gripe
RU2599496C2 (ru) 2012-03-06 2016-10-10 Круселл Холланд Б.В. Улучшенная вакцинация против гриппа
JP6152535B2 (ja) * 2012-04-16 2017-06-28 公益財団法人ヒューマンサイエンス振興財団 細胞培養組成物及びインフルエンザウイルスの生産方法
AU2013270793A1 (en) 2012-06-04 2014-12-11 Novartis Ag Improved safety testing
GB201218195D0 (en) 2012-10-10 2012-11-21 Istituto Zooprofilattico Sperimentale Delle Venezie Composition
AU2013354219A1 (en) 2012-12-03 2015-07-02 Novartis Ag Reassortant influenza a viren
HK1218511A1 (zh) 2013-03-13 2017-02-24 Novartis Ag 乙型流感病毒重配
JP2016521282A (ja) 2013-05-10 2016-07-21 ノバルティス アーゲー インフルエンザワクチンにおけるナルコレプシーのリスクの回避
DE202013005100U1 (de) 2013-06-05 2013-08-26 Novartis Ag Influenza Virus Reassortierung
DE202013005130U1 (de) 2013-06-05 2013-09-10 Novartis Ag Influenza Virus Reassortierung
JP2016521553A (ja) 2013-06-06 2016-07-25 ノバルティス アーゲー インフルエンザウイルス再集合
KR101370512B1 (ko) * 2013-06-07 2014-03-06 재단법인 목암생명공학연구소 무단백 배지에서 부유 배양되는 mdck 유래 세포주 및 상기 세포주를 이용하여 바이러스를 증식시키는 방법
AU2014290203B2 (en) 2013-07-15 2020-12-24 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in MDCK or vero cells or eggs
WO2015028546A1 (en) 2013-08-30 2015-03-05 Glaxosmithkline Biologicals S.A. Large scale production of viruses in cell culture
US20160287693A1 (en) 2013-11-15 2016-10-06 Novartis Ag Removal of residual cell culture impurities
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TW202246486A (zh) * 2014-06-09 2022-12-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
US10053671B2 (en) 2014-06-20 2018-08-21 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
AR102548A1 (es) 2014-11-07 2017-03-08 Takeda Vaccines Inc Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y uso
MA40920A (fr) 2014-11-07 2017-09-12 Takeda Vaccines Inc Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
US10238739B2 (en) 2014-12-02 2019-03-26 Novartis Ag Manufacture of surfactant-containing compositions with enhanced stability
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
AU2016281904B2 (en) 2015-06-26 2022-08-11 Seqirus UK Limited Antigenically matched influenza vaccines
WO2017007839A1 (en) 2015-07-06 2017-01-12 Wisconsin Alumni Research Foundation (Warf) Improved influenza virus replication for vaccine development
WO2017005880A1 (en) 2015-07-07 2017-01-12 Seqirus UK Limited Influenza potency assays
TWI781915B (zh) 2015-10-30 2022-11-01 財團法人國家衛生研究院 用於疫苗製備之於無血清、化學性界定培養基中之mdck懸浮細胞株
AU2017221444B2 (en) 2016-02-19 2021-07-29 Wisconsin Alumni Research Foundation (Warf) Improved influenza B virus replication for vaccine development
JP6933643B2 (ja) 2016-03-29 2021-09-08 一般財団法人阪大微生物病研究会 Ｍｄｃｋ細胞の培養方法
JP2017038622A (ja) * 2016-11-21 2017-02-23 ウィスコンシン アルムニ リサーチ ファンデイション Ｈ３型ウマａ型インフルエンザウイルス
US11197926B2 (en) 2017-10-25 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized HA for replication in eggs
CA3081581A1 (en) 2017-11-03 2019-05-09 Takeda Vaccines, Inc. Method for inactivating zika virus and for determining the completeness of inactivation
US12343390B2 (en) 2018-08-07 2025-07-01 Wisconsin Alumni Research Foundation (Warf) Recombinant biologically contained filovirus vaccine
US11389523B2 (en) 2018-08-20 2022-07-19 Wisconsin Alumni Research Foundation (Warf) Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
EP3914295A2 (en) 2019-01-23 2021-12-01 Yoshihiro Kawaoka Mutations that confer genetic stability to additional genes in influenza viruses
CN113874496A (zh) 2019-02-08 2021-12-31 威斯康星校友研究基金会(Warf) 人源化细胞系
WO2020223699A1 (en) 2019-05-01 2020-11-05 Wisconsin Alumni Research Foundation (Warf) Improved influenza virus replication for vaccine development
CA3137652A1 (en) 2019-05-08 2020-11-12 Takeda Vaccines, Inc. Inactivated virus compositions and zika vaccine formulations
JP7627911B2 (ja) 2019-08-27 2025-02-07 ウィスコンシン アルムニ リサーチ ファンデイション 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス
US12576146B2 (en) 2019-11-18 2026-03-17 Seqirus UK Limited Method for producing reassortant influenza viruses
WO2021150874A1 (en) 2020-01-24 2021-07-29 Wisconsin Alumni Research Foundation (Warf) Recombinant influenza viruses with stabilized na
WO2021195410A1 (en) 2020-03-25 2021-09-30 Wisconsin Alumni Research Foundation (Warf) Recombinant multivalent influenza viruses
JP2023532944A (ja) 2020-06-30 2023-08-01 セキラス ユーケー リミテッド 水中油型エマルジョンアジュバントの低温濾過
WO2023154043A1 (en) 2022-02-09 2023-08-17 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
CN116376810A (zh) * 2023-04-26 2023-07-04 上海奥浦迈生物科技股份有限公司 一种mdck细胞无血清贴壁培养驯化的方法
WO2025186793A1 (en) * 2024-03-08 2025-09-12 Seqirus Inc. Culture methods for virally-infected cells

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1278075B (de) 1964-06-22 1968-09-19 Norden Lab Inc Verwendung von Gewebekulturen zur Zuechtung von Viren fuer die Gewinnung von Impfstoffen
US3616203A (en) * 1969-12-11 1971-10-26 Norden Lab Inc Virus culture and method
US4064232A (en) 1974-01-14 1977-12-20 Sandoz Ltd. Process for isolating the immunogenic components of influenza viruses
CA1122527A (en) 1979-05-15 1982-04-27 Karen K. Brown Influenza vaccine production in liquid cell culture
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
US5013663A (en) * 1983-06-15 1991-05-07 American Home Products Corporation Canine corona virus vaccine
US4783411A (en) 1984-10-22 1988-11-08 Janis Gabliks Influenza-A virus vaccine from fish cell cultures
ES2081864T3 (es) 1989-03-29 1996-03-16 Univ New York State Res Found Metodo para purificar una proteina de la membrana exterior de haemophilus influenzae.
JP2827298B2 (ja) * 1989-07-10 1998-11-25 三菱化学株式会社 細胞培養担体
AT393277B (de) 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
JPH0420284A (ja) * 1990-05-12 1992-01-23 Mitsubishi Kasei Corp 細胞培養用マイクロキャリア
JPH05207873A (ja) * 1992-01-27 1993-08-20 Mitsubishi Kasei Corp 付着性動物細胞の培養方法
US5762939A (en) * 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
EP0791055B1 (en) 1994-11-10 2012-01-25 Baxter Healthcare S.A. Method for producing biologicals in protein-free culture
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
WO1996015232A1 (en) 1994-11-16 1996-05-23 St. Jude Children's Research Hospital Novel replication process
US5646033A (en) * 1994-11-30 1997-07-08 Dyncorp African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines
BR9610590A (pt) 1995-09-22 2000-10-24 Connaught Lab Glicoproteìnas e vacinas de vìrus parainfluenza
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
US6514502B1 (en) * 1999-01-26 2003-02-04 Schering-Plough Veterinary Corporation Propagation of bovine cononavirus in chinese hamster ovary cells

Similar Documents

Publication Publication Date Title
JP2009034115A5 (enExample)
JP2010275321A5 (enExample)
CN101695570B (zh) 一种手足口病单、双价灭活疫苗及其制备方法
JP2012526531A5 (enExample)
JP2005502357A5 (enExample)
JP2006230415A5 (enExample)
JP5980947B2 (ja) 高感染価のパルボウイルスの生産方法
RU2016114285A (ru) Вирусная вакцина и способы ее производства
CN117402813B (zh) 一种猫肾crfk贴壁细胞系的建立及悬浮驯化与应用
CN102796708A (zh) 一种增殖甲型流感病毒的方法
CN107523555A (zh) 获得病毒的方法
CN102284058A (zh) 复制缺陷型抗ev71和ca16病毒双价疫苗的制备方法
CN102526720B (zh) 一种流感病毒疫苗的制备方法
CN102911920A (zh) Ⅱ型登革病毒kmb17细胞适应株及其制备方法
CN103642760B (zh) 一种制备柯萨奇a16型病毒完整实心颗粒的方法
CN102614508B (zh) 一种人用流感病毒裂解疫苗的病毒裂解灭活方法
Pelz et al. Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus
CN106148289A (zh) 一种纯化戊型肝炎病毒的方法
KR101581228B1 (ko) 바이러스의 증식을 위한 ２-단계 온도 프로파일
RU2493872C1 (ru) Способ очистки вируса гриппа
CN116144610A (zh) 一种流感病毒裂解疫苗的制备方法
CN113913397A (zh) 一种溶瘤病毒的纯化方法
CN108795886B (zh) 一种病毒液的浓缩方法
CN114645024A (zh) 降低狂犬病病毒产品中细胞蛋白及dna残留的方法
TW202216992A (zh) 從細胞培養物中製備純化之桿狀病毒之方法